Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why Confluent Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket (Benzinga) +++ CONFLUENT Aktie -3,03%

OXFORD NANOPORE Aktie

 >OXFORD NANOPORE Aktienkurs 
1.51 EUR    +2.9%    (Tradegate)
Ask: 1.496 EUR / 3500 Stück
Bid: 1.47 EUR / 3500 Stück
Tagesumsatz: 1669 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>OXFORD NANOPORE Performance
1 Woche: -12,4%
1 Monat: -5,5%
3 Monate: -22,8%
6 Monate: +1,3%
1 Jahr: -21,7%
laufendes Jahr: -4,2%
>OXFORD NANOPORE Aktie
Name:  OXFORD NANOPORE TECHNOLOGIES
Land:  Großbritannien
Sektor:  Gesundheit
ISIN/ Wkn:  GB00BP6S8Z30 / A3C307
Symbol/ Ticker:  4R0 (Frankfurt)
Kürzel:  FRA:4R0, ETR:4R0, 4R0:GR
Index:  -
Webseite:  https://nanoporetech.com/
Profil:  Oxford Nanopore Technologies Ltd. is a transformat..
>Volltext..
Marktkapitalisierung:  1440.29 Mio. EUR
Unternehmenswert:  1104.97 Mio. EUR
Umsatz:  241.4 Mio. EUR
EBITDA:  -125.71 Mio. EUR
Nettogewinn:  -169.02 Mio. EUR
Gewinn je Aktie:  -0.18 EUR
Schulden:  52 Mio. EUR
Liquide Mittel:  228.89 Mio. EUR
Operativer Cashflow:  -105.75 Mio. EUR
Bargeldquote:  3.13
Umsatzwachstum:  20.49%
Gewinnwachstum:  11.03%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  OXFORD NANOPORE
Letzte Datenerhebung:  08.12.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 965.87 Mio. St.
Frei handelbar: 33.07%
Rückkaufquote: -6.59%
Mitarbeiter: 1480
Umsatz/Mitarb.: 0.13 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 54.95%
Bewertung:
KGV: -
KGV lG: -
KUV: 6.13
KBV: 2.36
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 57.32%
Gewinnmarge: -70.02%
Operative Marge: -74.79%
Managementeffizenz:
Gesamtkaprendite: -20.56%
Eigenkaprendite: -26.01%
>Peer Group

Es sind 82 Aktien bekannt.
 
08.12.25 - 12:24
Oxford Nanopore names new CEO, Harbour Energy agrees to sell Indonesian operations (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
08.12.25 - 09:24
Oxford Nanopore beruft Francis Van Parys zum neuen CEO (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
08.12.25 - 08:39
Appointment of Francis Van Parys as Chief Executive Officer (Business Wire)
 
OXFORD, England--(BUSINESS WIRE)--#Nanopore--Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive Officer (“CEO”). Francis will join the Company and the Board as an Executive Director on 2 March 2026. Francis brings more than 20 years of experience leading multi-billion-dollar life science businesses, with a strong track record of scaling innovation-driven organisations through commercial and operational excellence. He is currently President and CEO of Radiometer, a global leader in acute care diagnostics and part of Danaher Corporation. Previously, Francis held senior leadership roles at Cytiva and GE Healthcare, driving sustained growth and building high-performing teams across Europe, Asia, and North America. Francis Van Parys will succeed Gordon Sanghera, who has led Oxford Nanopore since its inception in 2005. Gordon will step down from the Board at close of...
13.11.25 - 16:03
New England Biolabs® launches the NEBNext® Flu A Integrated Indexing Primer Module to advance Influenza A surveillance and sequencing (PR Newswire)
 
Streamlined, high-throughput sequencing of Influenza A virus with integrated indexing for Oxford Nanopore Technologies® platforms IPSWICH, Mass., Nov. 13, 2025 /PRNewswire/ -- New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module......
07.11.25 - 12:12
Oxford Nanopore shares up as expects annual growth at top end of range (Alliance)
 
Oxford Nanopore Technologies PLC shares surged on Friday as it set out upbeat guidance for the full-year....
09.10.25 - 13:03
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 (PR Newswire)
 
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit Establishes a framework to define and propose future portfolios Extends collaboration through 2032, reinforcing Bio-Techne's......
06.10.25 - 17:06
Wasatch BioLabs Expands Service Portfolio with Oxford Nanopore Assays in Pharmacogenomics, Telomere Sequencing, and mRNA Vaccine Quality Control (PR Newswire)
 
SALT LAKE CITY, Oct. 6, 2025 /PRNewswire/ -- Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read sequencing, today announced the addition of three Oxford Nanopore–developed research-use-only (RUO)......
10.09.25 - 19:18
Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows (PR Newswire)
 
BOSTON, Sept. 10, 2025 /PRNewswire/ -- Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto™ platform to streamline sample preparation across multiple genomics workflows, supporting both Illumina and Oxford Nanopore Technologies (ONT)......
10.09.25 - 19:15
Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows (PR Newswire)
 
BOSTON, Sept. 10, 2025 /PRNewswire/ -- Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto™ platform to streamline sample preparation across multiple genomics workflows, supporting both Illumina and Oxford Nanopore Technologies (ONT)......
02.09.25 - 10:18
Oxford Nanopore loss narrows, despite reduced margin, on buoyant sales (Alliance)
 
Oxford Nanopore Technologies PLC on Tuesday backed guidance as growth across the business helped drive a 26% increase in...
02.09.25 - 08:36
Oxford Nanopore H1 revenue jumps 28%, loss narrows (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
30.08.25 - 10:24
Oxford Nanopore heads for interim results with investors wanting more detail on growth prospects (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
29.08.25 - 13:24
Oxford Nanopore heads for interim results with investors wanting more detail on growth prospects (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
11.08.25 - 17:24
Gordon Sanghera to step down as Oxford Nanopore CEO (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
11.08.25 - 12:18
IN BRIEF: Oxford Nanopore Technologies CEO to leave at end of 2026 (Alliance)
 
Oxford Nanopore Technologies PLC - Oxford, England-based specialist in DNA and RNA sequencing technologies - Chief Executive...
07.08.25 - 09:12
Oxford Nanopore suing MGI Australia over alleged patent infringements (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
21.07.25 - 17:00
Up 20%! Here’s why Oxford Nanopore stock topped the FTSE 250 today (Fool)
 
This under-the-radar growth stock in the FTSE 250 index just jumped to a 52-week high. Can it keep climbing higher from here? The post Up 20%! Here's why Oxford Nanopore stock topped the FTSE 250 today appeared first on The Motley Fool UK....
21.07.25 - 16:48
Oxford Nanopore leaps 20% after stronger first half trading (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
21.07.25 - 11:06
Oxford Nanopore shares climb after revenue rises 25% in first half (Alliance)
 
Oxford Nanopore Technologies PLC on Monday left its full-year outlook unchanged, though revenue was higher-than-expected in the first half of 2025.The Oxford,England-based biomedical company focuses......
21.07.25 - 10:18
Early market roundup: European stocks mixed but FTSE 100 above 9,000 (Alliance)
 
Stocks in Europe moved little on Monday morning but mining stocks enjoyed a boost, while Oxford Nanopore Technologies on the FTSE 250 rose as it......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer der Folter erlag, kann nicht mehr heimisch werden auf dieser Welt. - Jean Améry
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!